Completed PHASE4 INTERVENTIONAL 1-arm NCT03337373

The Study of Pharmacokinetics and Pharmacodynamics of Cisatracurium

The Study of Pharmacokinetics and Pharmacodynamics of a Loading Dose Cisatracurium in Critically Ill Patients

Sponsor: Mahidol University

Conditions ARDS, Human Critical Illness Neuromuscular Blockade Paralysis Respiratory Distress Syndrome, Adult Respiratory Failure

Interventions cisatracurium

Updated 7 times since 2017 Last updated: Mar 5, 2019 Started: Dec 15, 2017 Primary completion: Aug 31, 2018 Completion: Aug 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03337373, this PHASE4 trial focuses on ARDS, Human and Critical Illness and remains completed. Sponsored by Mahidol University, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Apr 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Enrolling By Invitation → Completed
Jun 2018 — Apr 2019 [monthly]

Enrolling By Invitation PHASE4

▶ Show 2 earlier versions

Jan 2018 — Jun 2018 [monthly]

Enrolling By Invitation PHASE4

Status: Not Yet Recruiting → Enrolling By Invitation
Dec 2017 — Jan 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mahidol University

Data source: Mahidol University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand